Oxygenta Pharmaceutical LimitedBSE: OXYGENTAPH

Oxygenta Pharmaceutical Limited Press Release Jul 21 2025

· Issued by Oxygenta Pharmaceutical Limited via BSE India

Filed with BSE ·

Compliance Certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended 30.06.2025.

View Attachment

6ix hasn’t read this filing yet.

Oxygenta Pharmaceutical Limited on 6ix

Earlier from Oxygenta Pharmaceutical

Later from Oxygenta Pharmaceutical

All Oxygenta Pharmaceutical news releases